WallStSmart
CNTN

Canton Strategic Holdings, Inc.

NASDAQ: CNTN · HEALTHCARE · BIOTECHNOLOGY

$3.51
-15.51% today

Updated 2026-06-02

Market cap
$187.08M
P/E ratio
P/S ratio
EPS (TTM)
$-0.36
Dividend yield
52W range
$1 – $9
Volume
0.6M

Canton Strategic Holdings, Inc. (CNTN) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item2019202020212022202320242025
Operating cash flow$-706113.00$-1.08M$-1.09M$-6.56M$-7.30M$-10.90M$-16.13M
Capital expenditures$3.00$0.00$4.00$0.00$4.00$0.00$77.57M
Depreciation
Stock-based comp$92012.00$234580.00$1.24M$800696.00$831862.00$710313.00$2.88M
Free cash flow$-706116.00$-1.08M$-1.09M$-6.56M$-7.30M$-10.90M$-93.70M
Investing cash flow
Financing cash flow
Dividends paid
Share repurchases
Debt repayment
Net change in cash

Frequently asked questions

How much free cash flow does CNTN generate?

CNTN produced $-93.70M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is CNTN's balance sheet healthy?

CNTN holds $17.03M in cash and equivalents against — in long-term debt, on $397.93M of shareholder equity. That debt is best read against the cash flow the business throws off each year.